Dr. Gail Roboz, MD
Claim this profileNYP/Weill Cornell Medical Center
Area of expertise
Acute Myelogenous Leukemia
Gail Roboz, MD has run 9 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:
Acute Myeloid Leukemia
Gail Roboz, MD has run 7 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Weill Cornell Medical College - New York-Presbyterian Hospital
NYP/Weill Cornell Medical Center
Clinical Trials Gail Roboz, MD is currently running
BP1002 + Decitabine
for Acute Myeloid Leukemia
This study evaluates the safety and tolerability of escalating doses of BP1002 (Liposomal Bcl-2 Antisense Oligodeoxynucleotide) in patients with refractory/relapsed AML. The study is designed to assess the safety profile, identify DLTs, biologically effective doses, PK, PD and potential anti-leukemic effects of BP1002 as single agent (dose escalation phase) followed by assessing BP1002 in combination with decitabine (dose expansion phase).
Recruiting
1 award
Phase 1
11 criteria
BP1001 + Venetoclax + Decitabine
for Acute Myeloid Leukemia
The primary objectives of this study are to assess: (1) whether the combination of BP1001 plus venetoclax plus decitabine provides greater efficacy (Complete Remission \[CR\], Complete Remission with incomplete hematologic recovery \[CRi\], Complete Remission with partial hematologic recovery \[CRh\], than venetoclax plus decitabine alone (by historical comparison) in participants with untreated AML that cannot or elect not to be treated with more intensive chemotherapy; (2) whether BP1001-based treatment provides greater efficacy (CR, CRi, CRh) than intensive chemotherapy (by historical comparison) in participants with refractory/relapsed AML.
Recruiting
1 award
Phase 2
More about Gail Roboz, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Gail Roboz, MD has experience with
- Venetoclax
- Azacitidine
- Decitabine
- CC-486
- Dexamethasone
- Cyclophosphamide
Breakdown of trials Gail Roboz, MD has run
Acute Myelogenous Leukemia
Acute Myeloid Leukemia
Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Gail Roboz, MD specialize in?
Gail Roboz, MD focuses on Acute Myelogenous Leukemia and Acute Myeloid Leukemia. In particular, much of their work with Acute Myelogenous Leukemia has involved BCOR positive patients, or patients who are i(17q) positive.
Is Gail Roboz, MD currently recruiting for clinical trials?
Yes, Gail Roboz, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Gail Roboz, MD has studied deeply?
Yes, Gail Roboz, MD has studied treatments such as Venetoclax, Azacitidine, Decitabine.
What is the best way to schedule an appointment with Gail Roboz, MD?
Apply for one of the trials that Gail Roboz, MD is conducting.
What is the office address of Gail Roboz, MD?
The office of Gail Roboz, MD is located at: NYP/Weill Cornell Medical Center, New York, New York 10065 United States. This is the address for their practice at the NYP/Weill Cornell Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.